Suppr超能文献

兔眼中三种植入的可降解生物聚合物的组织病理学

Histopathology of the three implanted degradable biopolymers in rabbit eye.

作者信息

Rönkkö Seppo, Rekonen Petri, Sihvola Roope, Kaarniranta Kai, Puustjärvi Tuomo, Teräsvirta Markku, Uusitalo Hannu

机构信息

Department of Ophthalmology, University of Kuopio, 70211 Kuopio, Finland.

出版信息

J Biomed Mater Res A. 2009 Mar 1;88(3):717-24. doi: 10.1002/jbm.a.31932.

Abstract

New straightforward applications of new biopolymers are needed in glaucoma surgery. The aim of this study was to compare biocompatibility of three biomaterials in rabbit eyes after deep sclerectomy; a collagen implant (AquaFlow) represented the "gold standard". A blend of 85:15 poly(L-lactide-co-glycolide) and 70:30 poly(L-lactide-co-1,3-trimethylene carbonate) copolymers in a molar ratio of 70:30 (Bio-1 = Inion GTR membrane) and poly(DL-lactide-co-glycolide with molar compositions of 50:50 (Bio-2) and 85:15 (Bio-3) were inserted into rabbits eyes. Bio-1, Bio-2 or Bio-3 caused very mild eye irritation or tissue response which was comparable to that of the collagen implant. The biodegradation time of Bio-1, Bio-2, and Bio-3 implants was over one year, 3 months and 6 months, respectively. Implant mapping by Fourier transform infrared (FTIR) microscopy revealed a heterogeneous distribution of degradation products throughout Bio-1, Bio-2, and Bio-3. All implants were surrounded by a very fine tissue capsule which was not visible after total degradation of the implants. The FTIR spectrum of tissue capsule around Bio-1 was almost identical to that around Bio-2 whereas significant differences were observed in the spectrum of the tissue capsule around Bio-3. Despite some differences in tissue response, all tested implants represent biologically acceptable materials for drainage devices in glaucoma surgery.

摘要

青光眼手术需要新型生物聚合物的新的直接应用。本研究的目的是比较三种生物材料在兔眼深层巩膜切除术后的生物相容性;一种胶原蛋白植入物(AquaFlow)代表“金标准”。将摩尔比为70:30的85:15聚(L-丙交酯-共-乙交酯)和70:30聚(L-丙交酯-共-1,3-三亚甲基碳酸酯)共聚物的混合物(Bio-1 = Inion GTR膜)以及摩尔组成分别为50:50(Bio-2)和85:15(Bio-3)的聚(DL-丙交酯-共-乙交酯)植入兔眼。Bio-1、Bio-2或Bio-3引起的眼部刺激或组织反应非常轻微,与胶原蛋白植入物相当。Bio-1、Bio-2和Bio-3植入物的生物降解时间分别超过一年、3个月和6个月。通过傅里叶变换红外(FTIR)显微镜进行的植入物图谱分析显示,降解产物在Bio-1、Bio-2和Bio-3中分布不均。所有植入物都被一层非常薄的组织包膜包围,在植入物完全降解后不可见。Bio-1周围组织包膜的FTIR光谱与Bio-2周围的几乎相同,而Bio-3周围组织包膜的光谱则存在显著差异。尽管在组织反应上存在一些差异,但所有测试的植入物都是青光眼手术引流装置生物学上可接受的材料。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验